Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only.
Scope of the Report:
In the last several years, the development of Liposomes Drug Delivery market is fast with an average growth rate of 13.52%. In 2017, the global revenue of Liposomes Drug Delivery market is nearly 2.30 billion USD.
North America dominated the market with market share of 42.44% due to the high medical level. Following North America, Europe is the second largest market with market share of 32.33%. Asian Pacific regions are the third largest market with developed countries like Japan and many developing countries like China. Its market share is about 23.81%.
The worldwide market for Liposome Drug Delivery (Liposomes Drug Delivery) is expected to grow at a CAGR of roughly 12.8% over the next five years, will reach 4750 million US$ in 2024, from 2600 million US$ in 2019, according to a new study.
This report focuses on the Liposome Drug Delivery (Liposomes Drug Delivery) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Gilead Sciences
Pacira
Sun Pharmaceutical
Johnson & Johnson
Luye Pharma
Sigma-Tau Group
Ipsen (Onivyde)
CSPC
Teva Pharmaceutical
Novartis
Fudan-Zhangjiang
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Others
Market Segment by Applications, can be divided into
Fungal Infection Therapy
Cancer & Tumor Therapy
Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Liposome Drug Delivery (Liposomes Drug Delivery) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Liposome Drug Delivery (Liposomes Drug Delivery), with price, sales, revenue and global market share of Liposome Drug Delivery (Liposomes Drug Delivery) in 2017 and 2018.
Chapter 3, the Liposome Drug Delivery (Liposomes Drug Delivery) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Liposome Drug Delivery (Liposomes Drug Delivery) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Liposome Drug Delivery (Liposomes Drug Delivery) market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Liposome Drug Delivery (Liposomes Drug Delivery) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Scope of the Report:
In the last several years, the development of Liposomes Drug Delivery market is fast with an average growth rate of 13.52%. In 2017, the global revenue of Liposomes Drug Delivery market is nearly 2.30 billion USD.
North America dominated the market with market share of 42.44% due to the high medical level. Following North America, Europe is the second largest market with market share of 32.33%. Asian Pacific regions are the third largest market with developed countries like Japan and many developing countries like China. Its market share is about 23.81%.
The worldwide market for Liposome Drug Delivery (Liposomes Drug Delivery) is expected to grow at a CAGR of roughly 12.8% over the next five years, will reach 4750 million US$ in 2024, from 2600 million US$ in 2019, according to a new study.
This report focuses on the Liposome Drug Delivery (Liposomes Drug Delivery) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Gilead Sciences
Pacira
Sun Pharmaceutical
Johnson & Johnson
Luye Pharma
Sigma-Tau Group
Ipsen (Onivyde)
CSPC
Teva Pharmaceutical
Novartis
Fudan-Zhangjiang
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Others
Market Segment by Applications, can be divided into
Fungal Infection Therapy
Cancer & Tumor Therapy
Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Liposome Drug Delivery (Liposomes Drug Delivery) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Liposome Drug Delivery (Liposomes Drug Delivery), with price, sales, revenue and global market share of Liposome Drug Delivery (Liposomes Drug Delivery) in 2017 and 2018.
Chapter 3, the Liposome Drug Delivery (Liposomes Drug Delivery) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Liposome Drug Delivery (Liposomes Drug Delivery) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Liposome Drug Delivery (Liposomes Drug Delivery) market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Liposome Drug Delivery (Liposomes Drug Delivery) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
